Picture of Soligenix logo

SNGX Soligenix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Soligenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-17.7-12.6-13.8-6.14-8.27
Depreciation
Non-Cash Items5.660.1260.70.9680.206
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.5090.6510.425-3.44-0.348
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-11.5-11.7-12.6-8.6-8.4
Capital Expenditures-0.007-0.012-0.013
Purchase of Fixed Assets
Cash from Investing Activities-0.007-0.012-0.013
Financing Cash Flow Items-0.798-0.667-0.003-0.927-0.753
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities24.719.10.0773.667.76
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.37.37-12.7-4.91-0.627